Cancer anemia Fatigue symptom
Conditions
Interventions
Group 1:Taoqishengxue Capsule+basic treatment
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients are diagnosed as tumours by clinical, pathological and/or cytological; 2. Patients meet the diagnostic criteria for mild or moderate anemia (mild anemia: Hb 90 to 120g/L or moderate anemia: Hb 60 to 90g/L); 3. Patients meet the syndrome differentiation standard of spleen and kidney deficiency syndrome; 4. Patients with symptoms of fatigue; 5. Aged 18 to 75 years; 6. life expecting longer than three months; 7. Any medication not be used to treat anemia and improving fatigue within one month before enrollment; 8. Voluntary subjects and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. With heart, liver, kidney and other important organ damage; 2. Pregnant women and mental patients; 3. With gastric cancer invading the blood vessels caused by hematemesis, blood in the stool and other major bleeding; 4. Patients did not use the drug as prescribed. 5. Patient was forced to interrupt treatment due to serious side effects during the treatment period; 6. Other clinical trials are underway. 7. Participated in other drug clinical trials one month before enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hb concentration;RBC;HCT;MCV;RDW;Anemia grading;Symptoms and signs; | — |
Secondary
| Measure | Time frame |
|---|---|
| WBC;PLT;EPO;Fe;VitB12;FOL;PTS;PTR;PT%;INR;APTT;FIB;TT;DD;5HT;ß-endorphin; | — |
Countries
China
Contacts
Public ContactCHEN Xinyi
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Outcome results
None listed